Keith G. Oldroyd

Active 1991–2025

Also published as
Keith G Oldroyd
119
Papers
31,693
Citations
75
h-index
116
i10-index

Citations

Citations per year for Keith G. Oldroyd1972: 1 citations1991: 1 citations1992: 1 citations1993: 1 citations1994: 1 citations1995: 1 citations1997: 1 citations1999: 3 citations2000: 1 citations2001: 2 citations2002: 2 citations2003: 13 citations2004: 1 citations2005: 10 citations2006: 9 citations2007: 10 citations2008: 22 citations2009: 27 citations2010: 60 citations2011: 104 citations2012: 140 citations2013: 174 citations2014: 155 citations2015: 159 citations2016: 203 citations2017: 193 citations2018: 263 citations2019: 800 citations2020: 1,038 citations2021: 949 citations2022: 872 citations2023: 664 citations2024: 1,037 citations2025: 446 citations2026: 43 citations1973–1990: no citations, so these years are not shown1996: no citations, so this year is not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,870 citing papers, 17.4% of this breakdownUnited Kingdom: 1,046 citing papers, 9.7% of this breakdownItaly: 788 citing papers, 7.3% of this breakdownChina: 647 citing papers, 6% of this breakdownGermany: 616 citing papers, 5.7% of this breakdownNetherlands: 584 citing papers, 5.4% of this breakdownCanada: 442 citing papers, 4.1% of this breakdownJapan: 398 citing papers, 3.7% of this breakdownFrance: 370 citing papers, 3.4% of this breakdownSpain: 345 citing papers, 3.2% of this breakdownSwitzerland: 344 citing papers, 3.2% of this breakdownSouth Korea: 327 citing papers, 3% of this breakdown
0%17.4%Other 27.9%

Fields

  • Medicine88.3%
  • Engineering5.8%
  • Biochemistry, Genetics and Molecular Biology3.1%
  • Immunology and Microbiology0.5%
  • Economics, Econometrics and Finance0.3%
  • Neuroscience0.3%
  • Other1.7%

Topics

  • Coronary Interventions and Diagnostics17.6%
  • Cardiac Imaging and Diagnostics16.6%
  • Acute Myocardial Infarction Research10.5%
  • Antiplatelet Therapy and Cardiovascular Diseases4.2%
  • Cardiovascular Function and Risk Factors3%
  • Mechanical Circulatory Support Devices2.6%
  • Other45.5%

Coauthors

All papers

Open in search
  1. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 4,209

  2. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,172

  3. Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 2,736

  4. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 775

  5. Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gabríel Steg, Giora Weisz, Bernhard Witzenbichler, Yaling Han, Stuart Pocock, C. Michael Gibson - New England Journal of Medicine 2019 cited by 1,000

  6. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 861

  7. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , - JAMA Cardiology 2021 cited by 245

  8. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Pernow - Circulation 2021 cited by 254

  9. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Mack, Tamás Szerafin, John K. Buckner, Myles S. Guber, Niels Verberkmoes, Ferdi Akca, Ted Feldman, Friedhelm Beyersdorf, Benny Drieghe, Keith G. Oldroyd, Geoff Berg, Anders Jeppsson, Kimberly Barber, Kevin Wolschleger, John Heiser, Pim van der Harst, Massimo A. Mariani, Hermann Reichenspurner, Christoffer Stark, Mika Laine, Paul C. Ho, John C. Chen, Richard Zelman, Phillip A. Horwitz, Andrzej Bochenek, Agata Krauze, Christina Grothusen, Dariusz Dudek, George P. Heyrich, Piroze Davierwala, Thilo Noack, Philippe Kolh, Victor Legrand, Pedro Coelho, Stephan Ensminger, Boris Nasseri, Richard Ingemansson, Göran Olivecrona, Javier Escaned, Reddy Guera, Sérgio Berti, Marie‐Claude Morice, Alaide Chieffo, M. Nicholas Burke, Michael Mooney, Alvise Spolaor, Christian Hagl, Michael Näbauer, Maarten J. Suttorp, Ronald A. Stine, Thomas McGarry, Scott Lucas, Knut Endresen, Andrew Taussig, Kevin Accola, Umberto Canosi, Iván Horváth, Louis Cannon, John D. Talbott, C W Akins, Robert S. Kramer, Michael Aschermann, William A. Killinger, Inga Narbute, David R. Holmes, Francesco Burzotta, Ad J.J.C. Bogers, Felix Zijlstra, Hélène Eltchaninoff, Jacques Berland and 26 more - The Lancet 2019 cited by 638

  10. Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victoria Y. Ding, Yuhei Kobayashi, Mark A. Hlatky, Kenneth W. Mahaffey, Manisha Desai, Y Joseph Woo, Alan C. Yeung, Nico H.J. Pijls - New England Journal of Medicine 2021 cited by 343

  11. One-Year Outcomes after PCI Strategies in Cardiogenic Shock

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steffen Schneider, Uwe Zeymer, Steffen Desch - New England Journal of Medicine 2018 cited by 431

  12. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2010 cited by 1,234

  13. Randomized Trial of Preventive Angioplasty in Myocardial Infarction

    Authors: , , , , , , , - New England Journal of Medicine 2013 cited by 1,038

  14. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2019 cited by 257

  15. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial

    Authors: , , , , , , , , , , , , , , - The Lancet 2015 cited by 616

  16. Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2010 cited by 1,133

  17. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 808

  18. Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 289

  19. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gabríel Steg, Giora Weisz, Bernhard Witzenbichler, Yaling Han, Stuart Pocock, C. Michael Gibson, Roxana Mehran - European Heart Journal 2020 cited by 176

  20. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Menown, Thor Trovik, Markku Eskola, Hannu Romppanen, Tholmas Kellerth, Lisette Okkels Jensen, Gintaras Kalinauskas, Rikard Linder, Markku O. Pentikäinen, Anders Hervold, Adrian Banning, Azfar Zaman, James Cotton, Erlend Eriksen, Sulev Margus, Lone J.H. Mogensen, Per Hostrup Nielsen, Matti Niemelä, Kari Kervinen, Jens Flensted Lassen, Keith G. Oldroyd, Geoff Berg, Simon Walsh, Colm G. Hanratty, Indulis Kumsārs, Pēteris Stradiņš, Terje K. Steigen, Ole Fröbert, Alastair N.J. Graham, Petter Cappelen Endresen, Matthias Corbascio, Olli A. Kajander, Uday Trivedi, Juha Hartikainen, Ves Anttila, David Hildick‐Smith, Leif Thuesen, Evald Høj Christiansen - The Lancet 2019 cited by 440

  21. Prognostic Value of the Index of Microcirculatory Resistance Measured After Primary Percutaneous Coronary Intervention

    Authors: , , , , , , , , , - Circulation 2013 cited by 421

  22. Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease

    Authors: , , , , , , , , , - JACC: Cardiovascular Interventions 2022 cited by 97

  23. Ischemia and No Obstructive Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Interventions 2019 cited by 176

  24. Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 1,050